A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.

A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.

Lenalidomide have both immunomodulatory and anti-angiogenic properties which could confer anti-cancer effects. The aim of this study was to assess the feasibility of combining lenalidomide with the standard treatment gemcitabine in pancreatic cancer patients with advanced disease.Eligible patients h...

Full description

Bibliographic Details
Main Authors:	Gustav J Ullenhag, Eva Rossmann, Maria Liljefors
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4383423?pdf=render

Similar Items

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.
by: Gustav J Ullenhag, et al.
Published: (2017-01-01)

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
by: Aerts Raymond, et al.
Published: (2008-09-01)

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)
by: Bernd Kasper, et al.
Published: (2015-01-01)

The role of biological dose-escalation for pancreatic cancer
by: Anna M.E. Bruynzeel, et al.
Published: (2019-09-01)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
by: Neoptolemos John P, et al.
Published: (2008-07-01)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
by: Lauren E. Colbert, MD, et al.
Published: (2018-10-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Phase I study of dose‐escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initial clinical results
by: Shuiwang Qing, et al.
Published: (2021-10-01)

A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
by: Devalingam Mahalingam, et al.
Published: (2018-05-01)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2018-11-01)

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
by: Jenny Bertholet, et al.
Published: (2019-05-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
by: Hakon Blomstrand, et al.
Published: (2019-01-01)

Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancreatic cancer
by: JI Hongbing, et al.
Published: (2016-03-01)

BI 6727 and gemcitabine combination therapy in pancreatic cancer
by: Jones, O. P.
Published: (2018)

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
by: Daniel A Monti, et al.
Published: (2012-01-01)

Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
by: Lee Jae, et al.
Published: (2005-07-01)

Pancreatic Cancer Chemoresistance to Gemcitabine
by: Manoj Amrutkar, et al.
Published: (2017-11-01)

Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
by: Xu Zhu, et al.
Published: (2018-02-01)

Pharmacokinetic and Pharmacodynamic Analysis of Gemcitabine and Birinapant Combinations in Pancreatic Cancer
by: Zhu, Xu
Published: (2017)

Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
by: Kraft Andrew S, et al.
Published: (2007-12-01)

Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
by: Hui-Jen Tsai, et al.
Published: (2021-03-01)

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
by: Jung Hoon Kim, et al.
Published: (2018-06-01)

Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
by: Prashant Vempati, et al.
Published: (2020-12-01)

Polymer coated gold nanoshells for combinational photochemotherapy of pancreatic cancer with gemcitabine
by: Mina Emamzadeh, et al.
Published: (2021-04-01)

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
by: Sylvie Négrier, et al.
Published: (2017-08-01)

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
by: Katz Frieder, et al.
Published: (2006-12-01)

Mechanisms of gemcitabine resistance in pancreatic cancer
by: Melling, J.
Published: (2017)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01)

369 Safety and pharmacodynamic activity of ATOR-1015, a CTLA-4 x OX40 bispecific antibody, in a phase 1 dose escalation study of patients with advanced solid malignancies
by: Gustav Ullenhag, et al.
Published: (2020-11-01)

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study
by: Xiaofei Zhu, et al.
Published: (2020-12-01)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-08-01)

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer
by: Scholz M, et al.
Published: (2017-03-01)

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
by: Moehler Markus, et al.
Published: (2011-08-01)

The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
by: Jalal Baig, et al.
Published: (2019-07-01)

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
by: Katrien De Wolf, et al.
Published: (2017-09-01)

Clinical effect of gemcitabine combined with high-intensity focused ultrasound in treatment of advanced pancreatic cancer: A Meta-analysis
by: ZI Li
Published: (2020-01-01)

Clinical effect of nanoparticle albumin-bound paclitaxel combined with gemcitabine in treatment of advanced pancreatic cancer: A meta-analysis
by: WANG Yun, et al.
Published: (2019-05-01)

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
by: Hinke Axel, et al.
Published: (2008-03-01)

Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer
by: Roman Huber, et al.
Published: (2017-09-01)